Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Pascolo

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
The Prostate|March 10, 2009
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancerSusan Feyerabend, Stefan Stevanovic, Cécile Gouttefangeas, et al.
Non-Coding RNA|January 15, 2021
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in MelanomaMarina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Non-Coding RNA|November 22, 2022
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5Marina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Cells|August 9, 2024
Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In VivoShahab Mamaghani, Rocco Roberto Penna, Julia Frei, et al.
Pharmaceutics|August 10, 2021
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell LymphomaMarina Tusup, Severin Läuchli, Natalia Teresa Jarzebska, et al.
European Journal of Immunology|April 16, 2005
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNABirgit Scheel, Regina Teufel, Jochen Probst, et al.
RNA Biology|August 22, 2022
The A to I editing landscape in melanoma and its relation to clinical outcomeAusteja Amweg, Marina Tusup, Phil Cheng, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2008
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patientsAshley J Knights, Natko Nuber, Christopher W Thomson, et al.
Cell Reports|March 2, 2025
Inflammatory cytokines mediate the induction of and awakening from metastatic dormancyPaulo Pereira, Joshua Panier, Marc Nater, et al.
International Immunology|December 30, 2004
The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cellsSteve Pascolo, Florent Ginhoux, Nihay Laham, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
The Prostate|March 10, 2009
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancerSusan Feyerabend, Stefan Stevanovic, Cécile Gouttefangeas, et al.
Non-Coding RNA|January 15, 2021
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in MelanomaMarina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Non-Coding RNA|November 22, 2022
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5Marina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Cells|August 9, 2024
Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In VivoShahab Mamaghani, Rocco Roberto Penna, Julia Frei, et al.
Pharmaceutics|August 10, 2021
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell LymphomaMarina Tusup, Severin Läuchli, Natalia Teresa Jarzebska, et al.
European Journal of Immunology|April 16, 2005
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNABirgit Scheel, Regina Teufel, Jochen Probst, et al.
RNA Biology|August 22, 2022
The A to I editing landscape in melanoma and its relation to clinical outcomeAusteja Amweg, Marina Tusup, Phil Cheng, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2008
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patientsAshley J Knights, Natko Nuber, Christopher W Thomson, et al.
Cell Reports|March 2, 2025
Inflammatory cytokines mediate the induction of and awakening from metastatic dormancyPaulo Pereira, Joshua Panier, Marc Nater, et al.
International Immunology|December 30, 2004
The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cellsSteve Pascolo, Florent Ginhoux, Nihay Laham, et al.
Pageof 8